Literature DB >> 7406111

Serologic cross-reactions with sera from patients with echinococcosis and cysticercosis.

P M Schantz, D Shanks, M Wilson.   

Abstract

Serum specimens from persons with pathologically confirmed Echinococcus granulosus hydatidosis and Taenia solium cysticercosis were tested in indirect hemagglutination tests using both Echinococcus and Taenia antigens. There were cross-reactions with most sera, and it was not possible to distinguish specific reactions by comparing titers with the homologous or heterologous antigens. Using immunoelectrophoresis or double diffusion tests with E. granulosus antigens, the Echinococcus-specific arc 5 was demonstrated in 11 of 21 hydatidosis sera and in 1 of 20 cysticercosis sera.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406111     DOI: 10.4269/ajtmh.1980.29.609

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Pre- and postsurgical detection of IgG, IgM, and IgA specific to hydatidosis by ELISA with purified antigen enriched with the 5/B antigen complex.

Authors:  Olga Doiz; Rafael Benito; Joaquina Gil; Almudena Rojas; M Carmen Rubio; Antonio Osuna
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Specific recognition of hydatid cyst antigens by serum IgG, IgE, and IgA using western blot.

Authors:  Y Sbihi; D Janssen; A Osuna
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Surgically managed human cystic echinococcosis in north-eastern Iran: a single center's experience from 2001 to 2008.

Authors:  Mohammad Ebrahimipour; Christine M Budke; Mohsen Najjari; Kambiz Yaghoobi
Journal:  J Parasit Dis       Date:  2017-03-30

4.  Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci.

Authors:  K Hubert; A Andriantsimahavandy; A Michault; M Frosch; F A Mühlschlegel
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

5.  Cerebral cysticercosis in a European patient: problems of disease activity and therapeutic implications.

Authors:  A Thie; L Lachenmayer; R Bialek; K Kunze
Journal:  Klin Wochenschr       Date:  1987-05-15

6.  The relationship of antibody levels to the clinical spectrum of human neurocysticercosis.

Authors:  D Zini; V J Farrell; A A Wadee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

7.  Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.

Authors:  I N Mohammad; D C Heiner; B L Miller; M A Goldberg; I G Kagan
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

8.  Analysis of taeniid antigens using monoclonal antibodies to Echinococcus granulosus antigen 5 and antigen B.

Authors:  D Liu; M D Rickard; M W Lightowlers
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 9.  Cysticercosis update.

Authors:  J S Grisolia
Journal:  West J Med       Date:  1984-06

10.  Serological differentiation between Echinococcus granulosus and E. multilocularis infections in man.

Authors:  B Gottstein; J Eckert; H Fey
Journal:  Z Parasitenkd       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.